Cargando…

Effect of anakinra in COVID-19

Detalles Bibliográficos
Autores principales:	Kooistra, Emma J, Waalders, Nicole J B, Kox, Matthijs, Pickkers, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380916/ https://www.ncbi.nlm.nih.gov/pubmed/32838316 http://dx.doi.org/10.1016/S2665-9913(20)30235-6

Ejemplares similares

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
por: Jansen, Aron, et al.
Publicado: (2023)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence
por: Smolders, Joost, et al.
Publicado: (2021)

Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Responses and Tolerance
por: Jansen, Aron, et al.
Publicado: (2022)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Fever in Sepsis: Still a Hot Topic
por: Leijte, Guus Pieter, et al.
Publicado: (2019)

Does subarachnoid haemorrhage affect the innate immune response?
por: Kox, Matthijs, et al.
Publicado: (2007)

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Long-Term Impairments Are Most Pronounced in Critically Ill Patients with COVID-19 with Severe Obesity
por: Kooistra, Emma, et al.
Publicado: (2022)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Clinical sepsis phenotypes in critically ill COVID-19 patients
por: Bruse, Niklas, et al.
Publicado: (2022)

The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH
por: Kavirayani, Akhila, et al.
Publicado: (2020)

Adrenomedullin: its double-edged sword during sepsis slices yet again
por: Kox, Matthijs, et al.
Publicado: (2014)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
por: van Berkel, Miranda, et al.
Publicado: (2020)

The value of D-dimer to predict pulmonary embolism in critically ill COVID-19 patients
por: van den Berg, M.J.W., et al.
Publicado: (2021)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?
por: Stolk, Roeland F., et al.
Publicado: (2021)

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
por: Kooistra, Emma J., et al.
Publicado: (2021)

A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
por: Kooistra, Emma J., et al.
Publicado: (2021)

Noradrenaline drives immunosuppression in sepsis: clinical consequences
por: Stolk, Roeland F., et al.
Publicado: (2020)

Gender-specific differences in outcome after trauma may be explained by differences in immunity
por: Eijk, Lucas T van, et al.
Publicado: (2014)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19
por: de Nooijer, Aline H., et al.
Publicado: (2021)

Modulation of Pain Sensitivity by a Hyperventilatory Breathing Exercise and Cold Exposure Training
por: Zwaag, Jelle, et al.
Publicado: (2023)

Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients
por: van Lier, Dirk, et al.
Publicado: (2021)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Current evidence on the use of anakinra in COVID-19
por: Khani, Elnaz, et al.
Publicado: (2022)

COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients
por: Kox, Matthijs, et al.
Publicado: (2020)

The Effects of Cold Exposure Training and a Breathing Exercise on the Inflammatory Response in Humans: A Pilot Study
por: Zwaag, Jelle, et al.
Publicado: (2022)

Anakinra in COVID-19: important considerations for clinical trials
por: King, Andrew, et al.
Publicado: (2020)

Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gq238g58k63l1rbrdlep0v28cd